zolpidem has been researched along with Pyrosis in 1 studies
Zolpidem: An imidazopyridine derivative and short-acting GABA-A receptor agonist that is used for the treatment of INSOMNIA.
zolpidem : An imidazo[1,2-a]pyridine compound having a 4-tolyl group at the 2-position, an N,N-dimethylcarbamoylmethyl group at the 3-position and a methyl substituent at the 6-position.
Excerpt | Relevance | Reference |
---|---|---|
"Symptom assessments using GerdQ and reflux monitoring were performed before and after a 28-day treatment with 5 mg lemborexant at bedtime." | 3.30 | Lemborexant Attenuates Regurgitation without Worsening Objective Parameters on Reflux Monitoring in Patients with Gastroesophageal Reflux Disease and Insomnia: A Single-Arm Proof-of-Concept Study. ( Hoshikawa, Y; Iwakiri, K; Kawami, N; Momma, E, 2023) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Hoshikawa, Y | 1 |
Momma, E | 1 |
Kawami, N | 1 |
Iwakiri, K | 1 |
1 trial available for zolpidem and Pyrosis
Article | Year |
---|---|
Lemborexant Attenuates Regurgitation without Worsening Objective Parameters on Reflux Monitoring in Patients with Gastroesophageal Reflux Disease and Insomnia: A Single-Arm Proof-of-Concept Study.
Topics: Esophageal pH Monitoring; Female; Gastroesophageal Reflux; Heartburn; Humans; Hypnotics and Sedative | 2023 |